BMA EBITDA Growth
-1.35%TTM
Period ending:
BMA TTM EBITDA YoY %%
368069.87%-95389.41%
2007-03-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
BMA ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 75 observations from Mar 31, 2007 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| -1.3456% | |
| 2,277.3667% | |
| 12.2644% | |
| -44.7054% | |
| -22.3064% | |
| -98.2303% | |
| -56.481% | |
| 135.4996% | |
| 138.8856% | |
| 865.4824% | |
| 892.843% | |
| 233.3049% | |
| 303.0749% | |
| 84.2044% | |
| 41.1508% | |
| 250.3443% | |
| 389.905% | |
| 1,079.3445% | |
| 134.8264% | |
| 113.9347% | |
| 100% | |
| 100% | |
| -3,166.4616% | |
| -1,446.966% | |
| -50,538.5126% | |
| 25.2602% | |
| 15.7494% | |
| 100% | |
| 98.4334% | |
| 59.998% | |
| 6.5287% | |
| -113.2116% | |
| -386.1527% | |
| -562.6946% | |
| -1,433.6753% | |
| -861.4848% | |
| -3,384.5375% | |
| -107.1825% | |
| -102.4077% | |
| -102.3763% | |
| -99.7506% | |
| 92.0768% | |
| 92.0491% | |
| 91.8594% | |
| 323,218.976% | |
| 111,972.022% | |
| 214,996.6713% | |
| 95,308.6233% | |
| 357.3744% | |
| -99.6788% | |
| -99.9108% | |
| -99.7986% | |
| -100.0673% | |
| 14.4842% | |
| 210.2431% | |
| 210.0396% | |
| 209.292% | |
| 44.1904% | |
| 38,795.5508% | |
| 15,740.6915% | |
| 34.0214% | |
| -29.1143% | |
| -100.1298% | |
| -100.2544% | |
| -67.7811% | |
| -26.9919% | |
| 15.4597% | |
| 60.0054% | |
| 56.0793% | |
| 24.1918% | |
| 15.9951% | |
| 32.2085% | |
| 106.4864% | |
| 330.5415% | |
| 2,005.7705% |
Compare ebitda growth
All BMA financial metrics · BMA stock overview · How to interpret financial metrics
